Justice-involved individuals are more likely to present with mental health and substance use challenges and use tobacco at high rates. Implementing evidence-based tobacco cessation strategies within correctional systems can reduce health disparities ...
Smoke-free environments in mental health and substance use treatment organizations can reduce tobacco use among these individuals and improve the health of the staff, and yet many mental health and ...
In the U.S., 34% of adults with mental health challenges who use tobacco identify as Black, and 32% identify as Hispanic/Latinx. Understanding this relationship between mental health and substance use ...
Varenicline, an FDA-approved prescription smoking cessation aid, is an effective evidence-based treatment for reducing tobacco use among individuals with mental health and substance use challenges. Join the National Behavioral Health ...
National, state, and local-level data sources are essential to address tobacco-related disparities among individuals with mental health and substance use challenges. But, knowing how to find, understand and apply these ...
Individuals with mental health and substance use challenges have lower-than-average cancer screening rates and are at greater risk of developing colorectal cancer than the general population. Integrating conversations around mental ...
Do you want to strengthen partnerships and collaborations with mental health and substance use treatment systems and providers to address tobacco-related disparities? Join us on May 10th, 2:30 – 3:30 p.m. ...
Join the National Behavioral Health Network for Tobacco and Cancer Control on Wednesday, May 11, 2:00 – 3:00 p.m. ET for a webinar designed to support organizations on addressing barriers ...
